Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125

Author：

E-ISSN： 1791-3004|12|4|5179-5184

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.4, 2015-01, pp. : 5179-5184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

By Granato Teresa

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1335-1339

Springer Publishing Company

Access to resources Recommend Favorite

An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions

By Macuks Ronalds

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1811-1817

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T. Marth C. Kaern J. Nustad K. Kristensen G.B. Trope C.

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A. Nielsen D. Engelholm S.A.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Serum CA-125 Screening for Ovarian Cancer in Patients with Dermatomyositis

By Whitmore S.E. Anhalt G.J. Provost T.T. Zacur H.A. Hamper U.M. Helzlsouer K.J. Rosenshein N.B.

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite